Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands
Laura Blaikie, Graeme Kay, Paul Kong Thoo Lin
MedChemComm (2019) Vol. 10, Iss. 12, pp. 2052-2072
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 35
Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
Mohammed Alsubaie, Suhuai Luo, Kamran Shaukat
Machine Learning and Knowledge Extraction (2024) Vol. 6, Iss. 1, pp. 464-505
Open Access | Times Cited: 23
Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery
Xueyang Jiang, Tingkai Chen, Junting Zhou, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 9, Iss. 3, pp. 171-176
Open Access | Times Cited: 92
Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)
João P. S. Ferreira, Hélio M. T. Albuquerque, Susana M. Cardoso, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113492-113492
Closed Access | Times Cited: 60
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease
Marta Campora, Valeria Francesconi, Silvia Schenone, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 1, pp. 33-33
Open Access | Times Cited: 59
Brain modulation by the gut microbiota: From disease to therapy
Sarmistha Mitra, Raju Dash, Amena Al Nishan, et al.
Journal of Advanced Research (2022) Vol. 53, pp. 153-173
Open Access | Times Cited: 47
Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer’s Disease
Abhinav Sharma, Lúcio Angnes, N. Sattarahmady, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 742-742
Open Access | Times Cited: 20
Alzheimer’s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma
Swathi Suresh, Ankul Singh S, Rapuru Rushendran, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 19
Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic model
Yanting Zhang, Hisanori Kiryu
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Capsaicin: A Potential Treatment to Improve Cerebrovascular Function and Cognition in Obesity and Ageing
Tammy Thornton, Dean E. Mills, Edward Bliss
Nutrients (2023) Vol. 15, Iss. 6, pp. 1537-1537
Open Access | Times Cited: 15
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 6
Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer’s Disease
Галина Ф. Махаева, N. V. Kovaleva, Елена В. Рудакова, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 321-321
Open Access | Times Cited: 5
Advanced Nano Delivery System for Stem Cell Therapy for Alzheimer's Disease
Yilong Pan, Long Li, Ning Cao, et al.
Biomaterials (2024) Vol. 314, pp. 122852-122852
Closed Access | Times Cited: 5
Pharmacophore-based virtual screening of the chromone derivatives as potential therapeutic for Alzheimer’s disease
Naveen Kumar, Bharti Devi, Kailash Jangid, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access
Design of BBB permeable BACE-1 inhibitor as potential drug candidate for Alzheimer Disease: 2D-QSAR, Molecular Docking, ADMET, Molecular Dynamics, MMGBSA
Navneet Kaur, Saurabh Gupta, Jayanta K. Pal, et al.
Computational Biology and Chemistry (2025) Vol. 116, pp. 108371-108371
Closed Access
Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review
Daniela Malafaia, Hélio M. T. Albuquerque, Artur M. S. Silva
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113209-113209
Closed Access | Times Cited: 37
Diagnostic and therapeutic potential of protease inhibition
Natalia Ćwilichowska, K. Świderska, Agnieszka Dobrzyń, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101144-101144
Closed Access | Times Cited: 24
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy
Marialuigia Fantacuzzi, Rosa Amoroso, Simone Carradori, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114242-114242
Closed Access | Times Cited: 22
Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease
Michele Tonelli, Marco Catto, Raimon Sabaté, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115169-115169
Open Access | Times Cited: 14
Recent developments of small molecule γ-secretase modulators for Alzheimer's disease
Shekar Mekala, Grady L. Nelson, Yue‐Ming Li
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 9, pp. 1003-1022
Open Access | Times Cited: 38
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer’s Disease
Marta Campora, Claudio Canale, Elena Gatta, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 3, pp. 447-461
Open Access | Times Cited: 29
An update on stem cell and stem cell-derived extracellular vesicle-based therapy in the management of Alzheimer’s disease
Madhan Jeyaraman, Ramya Lakshmi Rajendran, Sathish Muthu, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17808-e17808
Open Access | Times Cited: 10
Polymer–drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer's disease
Nuruddin Mahadik, Gemma A. Barron, Paul Kong Thoo Lin, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 2, pp. 161-181
Open Access | Times Cited: 3
Spatial–Temporal Mapping Reveals the Golgi as the Major Processing Site for the Pathogenic Swedish APP Mutation: Familial APP Mutant Shifts the Major APP Processing Site
Jingqi Wang, Paul A. Gleeson, Lou Fourrière
Traffic (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 3
Evaluation of 3,4-diethoxy substituted thioureas and their thiazole derivatives as potent anti-Alzheimer's agents: Synthesis, DFT, biological activity and molecular modeling investigations
Mahnoor Mahmood, Zahid Hussain, Muhammad Zahid Ullah, et al.
Journal of Molecular Structure (2024) Vol. 1314, pp. 138760-138760
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top